Syros pharmaceuticals yahoo finance

Author: mntg

August undefined, 2024

WebSyros Pharmaceuticals Inc. (SYRS) Stock Price Today, News, Quotes, FAQs and Fundamentals DIA 0.42% SPY 0.17% QQQ 0.55% Trending RIOT 14.56% AUPH 10.18% CRMD 9.44% WW 50.61% SNOW 6.27% SOL.X 12.85% TGTX 18.10% ZIM 12.88% JNUG 4.91% HKD 19.77% More Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. … WebJul 5, 2024 · CAMBRIDGE, Mass. & BEDMINSTER, N.J., July 05, 2024 -- ( BUSINESS WIRE )--Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and...

Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Tops ... - Yahoo

WebSyros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609. The company was founded by... WebApr 24, 2024 · Myriad Genetics, Inc. (MYGN) is scheduled to report third-quarter fiscal 2024 results on May 2, after the closing bell. either or and neither nor are examples of

SYRS -- Is Its Stock Price A Worthy Investment? Learn More.

WebView the latest Syros Pharmaceuticals Inc. (SYRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebApr 12, 2024 · Syros Pharmaceuticals - SYRS Stock Forecast, Price & News $2.56 +0.05 (+1.99%) (As of 04/10/2024 02:13 PM ET) Compare Today's Range $2.52 $2.58 50-Day … WebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies... food and beverage cos\u0027è

Syros Pharmaceuticals, Inc. (SYRS) - nz.finance.yahoo.com

Syros Announces Closing of Merger with Tyme Technologies and …

WebMar 8, 2024 · Discover historical prices for SYRS stock on Yahoo Finance. View daily, weekly or monthly formats back to when Syros Pharmaceuticals, Inc. stock was issued. WebPreviously, Mr. Nelsen served on the boards of Juno Therapeutics from August 2013 to March 2024, Syros Pharmaceuticals from August 2012 to June 2024, Sienna Biopharmaceuticals from August 2015 to October 2024, Agios Pharmaceuticals from December 2007 to June 2024, KYTHERA Biopharmaceuticals from January 2006 to … food and beverage cost percentagesWebSep 16, 2024 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced the closing of... either or are

"WebJun 27, 2024 · Nancy Simonian has been the CEO of Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) since 2012. First, this article will... " - Syros pharmaceuticals yahoo finance

Syros pharmaceuticals yahoo finance

WebNov 12, 2024 · Syros Pharmaceuticals, Inc.Which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.56 million for the quarter ended September 2024, surpassing the Zacks... WebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues …

Did you know?

WebSyros Pharmaceuticals, Inc. (SYRS) delivered earnings and revenue surprises of -0.79% and 123.02%, respectively, for the quarter ended December 2024. Do the numbers hold clues … WebSyros Pharmaceuticals, Inc. (SYRS) Analyst Ratings, Estimates & Forecasts - Yahoo Finance S&P/TSX 19,501.49 +41.59(+0.21%) S&P 500 3,970.99 +22.27(+0.56%) DOW 32,237.53 …

WebSep 16, 2024 · Shares of the combined company will trade on Nasdaq under the ticker symbol “SYRS.” Concurrent with the closing of the merger, Syros also closed the previously announced oversubscribed $130 million private investment in public equity (PIPE) financing. WebSyros Pharmaceuticals Inc (SYRS) Stock Price & News - Google Finance 19.30 Home SYRS • NASDAQ Syros Pharmaceuticals Inc Follow Share $2.71 Mar 30, 2:59:38 PM GMT-4 · USD · NASDAQ ·...

WebSep 23, 2024 · Syros Pharmaceuticals, Inc. (SYRS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might … WebMar 31, 2024 · Meanwhile, Syros Pharmaceuticals’ current year figures are also looking quite promising, with two estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from $2.57 per share 30 days ago to $2.32 per share today, an increase of 9.7%.

WebSyros Pharmaceuticals, Inc. (SYRS) Company Profile & Facts - Yahoo Finance S&P/TSX S&P 500 DOW Bitcoin CAD Syros Pharmaceuticals, Inc. (SYRS) NasdaqGS - NasdaqGS Real …

either or audiobookWebYahoo March 2, 2024 CAMBRIDGE, Mass., March 02, 2024--Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today reported financial results for the quarter and full-year ended December 31, 2024 and provided a corporate update. either/or argumentWebSyros Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag Syros Pharmaceuticals ( NASDAQ:SYRS ) Full Year 2024 Results Key Financial Results … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock discussion in Yahoo … Discover historical prices for SYRS stock on Yahoo Finance. View daily, weekly or … Syros Pharmaceuticals, Inc. (SYRS) NasdaqGS - NasdaqGS Real Time Price. … Find out the direct holders, institutional holders and mutual fund holders for … See the company profile for Syros Pharmaceuticals, Inc. (SYRS) including … See Syros Pharmaceuticals, Inc. (SYRS) stock analyst estimates, including … Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q4 2024 Earnings Call … Find out all the key statistics for Syros Pharmaceuticals, Inc. (SYRS), including … View the basic SYRS option chain and compare options of Syros … Find the latest Syros Pharmaceuticals, Inc. (SYRS) stock quote, history, news and … either or argument definition